Cemiplimab and Cutaneous Squamous Cell Carcinoma: From Bench to Bedside

This publication has 25 references indexed in Scilit:

• Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the US Population, 2012
  JAMA Dermatology, 2015
• Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline
  European Journal of Cancer, 2015
• Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: A Rochester Epidemiology Project population-based study in Minnesota
  Journal of the American Academy of Dermatology, 2015
• HIV Infection Status, Immunodeficiency, and the Incidence of Non-Melanoma Skin Cancer
  JNCI: Journal of the National Cancer Institute, 2013
• Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
  New England Journal of Medicine, 2012
• Distant metastases from cutaneous squamous cell carcinoma—analysis of AJCC stage IV
  Head & Neck, 2012
• A systematic review of worldwide incidence of nonmelanoma skin cancer
  British Journal of Dermatology, 2012
• The PDL1-PD1 Axis Converts Human T _H 1 Cells into Regulatory T Cells
  Science Translational Medicine, 2011
• CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
  Molecular and Cellular Biology, 2005
• The Three Es of Cancer Immunoediting
  Annual Review of Immunology, 2004